This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Is Veeva (VEEV) a Solid Growth Stock? 3 Reasons to Think " Yes "
by Zacks Equity Research
Veeva (VEEV) could produce exceptional returns because of its solid growth attributes.
Veeva (VEEV) Down 0.8% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Veeva (VEEV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
AngioDynamics (ANGO) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
AngioDynamics (ANGO) witnesses revenue growth across two business segments in fiscal Q3.
Software is the New Gold: Storing Value in the Digital-Crypto Age
by Kevin Cook
Time for the final nail in the gilded sarcophagus of the barbarous relic.
Boehringer Ingelheim Adopts Veeva's (VEEV) CRM Solution
by Zacks Equity Research
Veeva's (VEEV) CRM Engage Meeting enables Boehringer Ingelheim to host more than a million virtual meetings to stay connected with physicians.
Veeva (VEEV) Partners With Impel, Boosts Cloud-Based Offerings (Revised)
by Zacks Equity Research
Veeva (VEEV) collaborates with Impel to accelerate the pre-launch planning and digital-first commercial execution for migraine treatment.
Veeva (VEEV) Application Completes Consent for First Patient (Revised)
by Zacks Equity Research
With this latest development, Veeva (VEEV) is likely to strengthen its portfolio of cloud-based offerings.
Veeva (VEEV) Application Completes Consent for First Patient
by Zacks Equity Research
With this latest development, Veeva (VEEV) is likely to strengthen its portfolio of cloud-based offerings.
Looking for a Growth Stock? 3 Reasons Why Veeva (VEEV) is a Solid Choice
by Zacks Equity Research
Veeva (VEEV) possesses solid growth attributes, which could help it handily outperform the market.
Zacks.com featured highlights include: GMS, Veeva Systems, HarborOne Bancorp, SVB Financial and Safehold
by Zacks Equity Research
Zacks.com featured highlights include: GMS, Veeva Systems, HarborOne Bancorp, SVB Financial and Safehold
Top 5 Stocks to Buy Now for Blowout Earnings Growth
by Tirthankar Chakraborty
GMS, Safehold (SAFE), Veeva Systems (VEEV), HarborOne Bancorp(HONE) & SVB Financial (SIVB) are solid five stocks with striking earnings growth and positive estimate revisions.
Veeva Systems (VEEV) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Veeva Systems' (VEEV) core Subscription business and Professional Service segments perform impressively in fiscal Q4.
Veeva Systems (VEEV) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Veeva (VEEV) delivered earnings and revenue surprises of 14.71% and 4.44%, respectively, for the quarter ended January 2021. Do the numbers hold clues to what lies ahead for the stock?
This Week's 5 Red-Hot Earnings Charts
by Tracey Ryniec
These stocks are all up big in the last year but can they keep their momentum in 2021 as the global economy reopens?
This Week's 5 Red-Hot Earnings Charts
by Tracey Ryniec
These stocks are all up big in the last year but can they keep their momentum in 2021 as the global economy reopens?
Veeva Systems (VEEV) to Post Q4 Earnings: What's in Store?
by Zacks Equity Research
Veeva Systems' (VEEV) fiscal fourth-quarter results are likely to reflect solid show by its segments and robust product portfolio.
Veeva (VEEV) Partners With Impel, Boosts Cloud-Based Offerings
by Zacks Equity Research
Veeva (VEEV) collaborates with Impel to accelerate the pre-launch planning and digital-first commercial execution for migraine treatment.
Veeva Systems (VEEV) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Veeva Systems (VEEV) closed at $309.40 in the latest trading session, marking a -0.5% move from the prior day.
Veeva Systems (VEEV) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Veeva Systems (VEEV) closed at $290 in the latest trading session, marking a +1.38% move from the prior day.
Veeva Systems (VEEV) Stock Moves -0.1%: What You Should Know
by Zacks Equity Research
In the latest trading session, Veeva Systems (VEEV) closed at $292.22, marking a -0.1% move from the previous day.
Why You Should Retain Veeva (VEEV) in Your Portfolio Now?
by Zacks Equity Research
Investor confidence/optimism is high on Veeva (VEEV) stock, driven by its solid prospects.
Why Is Veeva (VEEV) Up 1.3% Since Last Earnings Report?
by Zacks Equity Research
Veeva (VEEV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
5 SaaS Stocks That Crushed the FAANGs This Year
by Shalu Saraf
Here we pick five SaaS stocks, TTD, ZS, ZEN, VEEV and DOCU, that have gained more than 70% YTD on massive demand for digital transformation and cloud computing services.
Veeva (VEEV) Vault QMS Gets Picked by Samsung Biologics
by Zacks Equity Research
Veeva Systems' (VEEV) Vault Quality Suite gets selected by Samsung Biologics to drive quality process and content management for better visibility across the latter's global processes.
Simbec-Orion to Adopt Veeva's (VEEV) Vault Applications
by Zacks Equity Research
Veeva's (VEEV) clinical solutions will offer Simbec-Orion real-time insights into studies in phases to accelerate trial execution.